Balma, France

Marc Payard


Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
4 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will craft an article about the inventor Marc Payard based on the provided data.

**Title: Unveiling the Inventive Journey of Marc Payard from Balma, FR**

Introduction:

Marc Payard, a prolific inventor hailing from Balma, FR, has made significant contributions to the field of pharmaceuticals through his innovative patents.

Latest Patents:

Among his latest patents are groundbreaking inventions such as Imidazoline compounds and Benzopyran derivatives. The Imidazoline compounds, with a compound formula (I), have shown promise as Imidazoline receptor ligands in medicinal products. Additionally, the Benzopyran derivatives, characterized by formula (I), have demonstrated effectiveness in treating diseases associated with sigma receptors.

Career Highlights:

Marc Payard is a distinguished member of the research and development team at Adir Et Compagnie. His innovative mindset and dedication have led to the successful filing of four patents, showcasing his expertise in the pharmaceutical industry.

Collaborations:

Throughout his career, Marc Payard has collaborated closely with accomplished professionals in the field. Notable coworkers include Genevieve Baziard-Mouysset and Daniel-Henri Caignard, who have further enriched the innovative work environment at Adir Et Compagnie.

Conclusion:

In conclusion, Marc Payard's inventive spirit and intellectual prowess have propelled him to the forefront of pharmaceutical innovation. His patents stand as a testament to his commitment to advancing healthcare through novel discoveries, making him a valuable asset in the realm of inventions and research.

If you have any more requests or need further information about inventors, inventions, or patents, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…